Interestingly, PDE4 inhibitors have been shown to improve motor function in a mouse model of Batten disease, a lysosomal storage disorder, which features parkinsonism,76 but failed to improve parkinsonism in humans in a small, double‐blind, crossover trial.77 This evidence concerns the gene PDE4A and Parkinson disease.